Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26    entities : Essa pharma inc.    save search
ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
EPIX | $6.53 2.03% 7.3K twitter stocktwits trandingview |
Health Technology
 | | O: 19.19% H: 148.78% C: 135.12%
pharma preclinical symposium
Updated Results from the Phase 1/2 Study of ESSA's Lead Candidate EPI-7386 in Combination with Enzalutamide Highlighted at the 29th Annual Prostate Cancer Foundation Scientific Retreat
Published: 2022-10-26 (Crawled : 14:00) - biospace.com/
EPIX | $6.53 2.03% 7.3K twitter stocktwits trandingview |
Health Technology
 | | O: 19.19% H: 148.78% C: 135.12%
epi-7386 candidate results cancer study prostate cancer phase 1
Gainers vs Losers
54% 46%

Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M twitter stocktwits trandingview |
Consumer Services
CZOO | $11.04 121.24% 9.6M twitter stocktwits trandingview |

BOF | $2.05 75.21% 78M twitter stocktwits trandingview |

AMST | $3.2 60.0% 63M twitter stocktwits trandingview |
Technology Services
LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.05 44.75% 13M twitter stocktwits trandingview |
Technology Services
TROO | $1.51 38.53% 5.6M twitter stocktwits trandingview |
Manufacturing
MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information
RILY | $28.605 31.7% 9.9M twitter stocktwits trandingview |
Finance
RBBN 4 | $3.305 28.6% 1.9M twitter stocktwits trandingview |
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.